HRT Financial’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

HRT Financial’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,000	Closed	-$204K	–	3647
2023 Q1	$204K	Hold	20,000	–	–	﹤0.01%	1921
2022 Q4	$201K	Buy	20,000 +210	+1%	+$2.09K	﹤0.01%	1935
2022 Q3	$195K	Sell	19,790 -354	-2%	-$3.47K	﹤0.01%	2223
2022 Q2	$196K	Buy	20,144 +144	+0.7%	+$1.41K	﹤0.01%	2256
2022 Q1	$195K	Hold	20,000	–	–	﹤0.01%	2496
2021 Q4	$196K	Buy	+20,000	New	+$196K	﹤0.01%	2544

HRT Financial's ORIA Position: Q2 2023 in Review

HRT Financial sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 20,000 shares — an estimated $204K sold.

HRT Financial first reported a position in ORIA in Q4 2021 and held it in 6 quarters. The position peaked at $204K in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

HRT Financial reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
HRT Financial sold 20,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $204K.
HRT Financial first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2021 and held it in 6 quarters.
HRT Financial's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $204K in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.